View Item 

Show simple item record

Evidence-based prescription of corticosteroids for COVID-19 patients: A comparison between general medicine and other specialty in Japan
dc.contributor.authorSakaguchi, Kota
dc.contributor.authorWatari, Takashi
dc.contributor.authorTokuda, Yasuharu
dc.date.accessioned2023-04-04T17:41:55Z
dc.date.available2024-04-04 13:41:54en
dc.date.available2023-04-04T17:41:55Z
dc.date.issued2023-03
dc.identifier.citationSakaguchi, Kota; Watari, Takashi; Tokuda, Yasuharu (2023). "Evidence-based prescription of corticosteroids for COVID-19 patients: A comparison between general medicine and other specialty in Japan." Journal of General and Family Medicine (2): 135-138.
dc.identifier.issn2189-7948
dc.identifier.issn2189-7948
dc.identifier.urihttps://hdl.handle.net/2027.42/176076
dc.description.abstractBackgroundThe difference of evidence-based prescription for COVID-19 patients between general medicine and other specialty in Japan is unclear.MethodsA retrospective observational study using a hospital-based administrative database was conducted for the differences between departments for prescriptions of glucocorticoids in COVID-19 patients.ResultsOf 65,156 patients, 23,348 met indication for glucocorticoids. General medicine physicians in Japan were more likely to prescribe corticosteroids for COVID-19 patients than other departments after its evidence was published (adjusted odds ratio, 1.32; p < 0.001; 95% confidence interval, 1.11–1.56).ConclusionsGeneral medicine physicians were more likely to practice evidence-based care for COVID-19 patients.This study aimed to compare glucocorticoid prescriptions issued by different medical departments in Japan, during the COVID-19 pandemic.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherCOVID-19
dc.subject.otherpharmacoepidemiology
dc.subject.otherpandemic
dc.subject.otherglucocorticoids
dc.subject.otherprescription
dc.titleEvidence-based prescription of corticosteroids for COVID-19 patients: A comparison between general medicine and other specialty in Japan
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelFamily Medicine
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/176076/1/jgf2602_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/176076/2/jgf2602.pdf
dc.identifier.doi10.1002/jgf2.602
dc.identifier.sourceJournal of General and Family Medicine
dc.identifier.citedreferenceRECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021; 384: 693 – 704.
dc.identifier.citedreferenceGarg M, Wray CM. Hospital medicine management in the time of COVID19: preparing for a sprint and a marathon. J Hosp Med. 2020; 15: 305 – 7.
dc.identifier.citedreferenceBowden K, Burnham EL, Keniston A, Levin D, Limes J, Persoff J, et al. Harnessing the power of hospitalists in operational disaster planning: COVID-19. J Gen Intern Med. 2020; 35: 2732 – 7.
dc.identifier.citedreferenceJapan Ministry of Health, Labour and Welfare. Coronavirus (COVID-19). Available from: https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou.html. Accessed 20 Mar 2022.
dc.identifier.citedreferenceBiala D, Siegel EJ, Silver L, Schindel B, Smith KM. Deployed: pediatric residents caring for adults during COVID-19’s first wave in new York City. J Hosp Med. 2020; 15: 763 – 4.
dc.identifier.citedreferenceKim MK, Rabinowitz LG, Nagula S, Dunn A, Chalil J, Xu T, et al. A primer for clinician deployment to the medicine floors from an epicenter of COVID-19. NEJM Catalyst. 2020.
dc.identifier.citedreferenceCraig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008; 337: a1655.
dc.identifier.citedreferenceJapanese Medical Specialty Board. 2018. [cited 25 June 2019]. Available from: https://www.japan-senmon-i.jp/. Accessed 29 Aug 2020.
dc.identifier.citedreferenceMedical Data Vision Co., Ltd. MDV Database. Available from: https://en.mdv.co.jp. Accessed 14 Apr 2022.
dc.identifier.citedreferenceNärhi F, Moonesinghe SR, Shenkin SD, Drake TM, Mulholland RH, Donegan C, et al. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO clinical characterisation protocol UK: prospective, cohort study. Lancet Digit Health. 2022; 4: e220 – 34.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jgf2602_am.pdf
Size:
785.7KB
Format:
PDF
View/Open
Name:
jgf2602.pdf
Size:
292.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.